Artios Pharma Is An Independent Biotechnology Company Based In The Ukfocused On Developing Dna Damage Responseddrtherapies For Cancer Treatmentthe Company Aims To Create Innovative Drugs That Provide Significant Therapeutic Benefits For Patients With Challenging Solid Tumorsartios Is Led By Experienced Professionalsincluding Ceo Niall Martin And Cso Graeme Smithwho Have A Strong Background In Ddr And Have Contributed To The Development Of Notable Cancer Therapies The Company Is Advancing A Robust Pipeline Of Therapeutic Candidatesincluding The Atr Inhibitor Art0380Targeting Various Ddr Pathwaysartios Employs A Comprehensive Approach To Cancer Treatmentexploring A Wide Range Of Ddr Based Therapeutic Opportunitieswhile It Does Not Offer Direct Clinical Servicesartios Is Dedicated To Discovering And Developing Precision Medicines To Improve Outcomes For Patients With Hard To Treat Cancers
